A carregar...
Concerns about unapproved meningococcal vaccination for eculizumab therapy in Japan
An orphan medicinal product, eculizumab is approved in Japan and globally for treating paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Eculizumab therapy can cause late complement pathway deficiencies that predispose patients to meningococcal infections. Although meningoc...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3990028/ https://ncbi.nlm.nih.gov/pubmed/24716834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1750-1172-9-48 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|